Profile of fungal infections in the post-pandemic period in a hospital in Campos Gerais
DOI:
https://doi.org/10.33448/rsd-v13i9.46929Keywords:
Brazil; Candida; Corticosteroids; Healthcare associated infections; Fungal infections; Catheter-related infections.Abstract
Introduction: Healthcare-associated infections cause public health problems worldwide, and fungi have increasingly stood out in this context, especially after the COVID-19 pandemic and the alert regarding the spread of the potentially multidrug-resistant species Candida auris. Objective: to determine the profile of healthcare-associated fungal infections in the post-pandemic period. Methodology: This is a retrospective cross-sectional study carried out by collecting patient data from electronic medical records in a hospital in southern Brazil. Results: The prevalence of fungal infections was 6%, higher in females (68.5%), with a mortality rate of 74% and association with multiple comorbidities, invasive devices, antibiotic therapy, and corticosteroid therapy. The most prominent species was Candida albicans, which represented 47.4% of all infections, in addition to a rare case of infection by Saccharomyces cerevisiae and no Candida auris strain being isolated. The use of antibiotics was present in 93.2% of patients, antifungals in 30.1%, and corticosteroids in 38.4%. Conclusion: Fungal infections associated with healthcare were associated with the profile of elderly patients, presence of comorbidities, hospitalization in intensive care unit beds and presented a high mortality rate.
References
Ali, G. A., Husain, A., Salah, H., & Goravey, W. (2021). Trichosporon asahii fungemia and COVID-19 co-infection: An emerging fungal pathogen; case report and review of the literature. IDCases, 25, e01244. https://doi.org/10.1016/j.idcr.2021.e01244
Almeida Júnior, J. N. de, Brandão, I. B., Francisco, E. C., de Almeida, S. L. R., de Oliveira Dias, P., Pereira, F. M., Santos Ferreira, F., de Andrade, T. S., de Miranda Costa, M. M., de Souza Jordão, R. T., Meis, J. F., & Colombo, A. L. (2021). Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil. Mycoses, 64(9), Artigo 9. https://doi.org/10.1111/myc.13320
Almeida Júnior, J. N. de, Francisco, E. C., Hagen, F., Brandão, I. B., Pereira, F. M., Presta Dias, P. H., de Miranda Costa, M. M., de Souza Jordão, R. T., de Groot, T., & Colombo, A. L. (2021). Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit. Journal of Fungi (Basel, Switzerland), 7(3), Artigo 3. https://doi.org/10.3390/jof7030220
Aquino, V. R., Lunardi, L. W., Goldani, L. Z., & Barth, A. L. (2005). Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil. Brazilian Journal of Infectious Diseases, 9(5), 411–418. https://doi.org/10.1590/S1413-86702005000500009
Barros, P. P. de, Rossoni, R. D., De Souza, C. M., Scorzoni, L., Fenley, J. D. C., & Junqueira, J. C. (2020). Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges. Mycopathologia, 185(3), 415–424. https://doi.org/10.1007/s11046-020-00445-w
Braga, I. A., Campos, P. A., Gontijo-Filho, P. P., & Ribas, R. M. (2018). Multi-hospital point prevalence study of healthcare-associated infections in 28 adult intensive care units in Brazil. Journal of Hospital Infection, 99(3), 318–324. https://doi.org/10.1016/j.jhin.2018.03.003
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. (2020). Conceitos e definições. Ministério da Saúde.
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. (2021) Programa nacional de prevenção e controle de infecções relacionadas à assistência à saúde (PNPCIRAS) 2021 a 2025. Agência Nacional de Vigilância Sanitária.
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. (2022). Confirmado novo caso de Candida auris no Brasil: Agência orienta que laboratórios de microbiologia intensifiquem a vigilância laboratorial para identificação de casos. Ministério da Saúde. https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2022/confirmado-novo-caso-decandida-aurisno-brasil
Brescini, L., Mazzanti, S., Morroni, G., Pallotta, F., Masucci, A., Orsetti, E., Montalti, R., & Barchiesi, F. (2022). Candidemia in Internal Medicine: Facing the New Challenge. Mycopathologia, 187(2–3), Artigo 2–3. https://doi.org/10.1007/s11046-022-00624-x
Carestia, M., Andreoni, M., Buonomo, E., Ciccacci, F., De Angelis, L., De Carolis, G., De Filippis, P., Di Giovanni, D., Emberti Gialloreti, L., Fontana, C., Guarente, L., Magrini, A., Mattei, M., Moramarco, S., Morciano, L., Mosconi, C., Orlando, S., Quintavalle, G., Riccardi, F., & Palombi, L. (2023). A novel, integrated approach for understanding and investigating Healthcare Associated Infections: A risk factors constellation analysis. PLOS ONE, 18(3), e0282019. https://doi.org/10.1371/journal.pone.0282019
Choi, J., & Kim, S.-H. (2017). A genome Tree of Life for the Fungi kingdom. Proceedings of the National Academy of Sciences, 114(35), 9391–9396. https://doi.org/10.1073/pnas.1711939114
Dabar, G., Harmouche, C., Salameh, P., Jaber, B. L., Jamaleddine, G., Waked, M., & Yazbeck, P. (2015). Community- and healthcare-associated infections in critically ill patients: A multicenter cohort study. International Journal of Infectious Diseases, 37, 80–85. https://doi.org/10.1016/j.ijid.2015.05.024
Deptuła, A., Trejnowska, E., Dubiel, G., Wanke-Rytt, M., Deptuła, M., & Hryniewicz, W. (2018). Healthcare associated bloodstream infections in Polish hospitals: Prevalence, epidemiology and microbiology—summary data from the ECDC Point Prevalence Survey of Healthcare Associated Infections 2012–2015. European Journal of Clinical Microbiology & Infectious Diseases, 37(3), 565–570. https://doi.org/10.1007/s10096-017-3150-1
Ebner, J., Van Den Nest, M., Bouvier-Azula, L., Füszl, A., Gabler, C., Willinger, B., Diab-Elschahawi, M., & Presterl, E. (2022). Routine Surveillance of Healthcare-Associated Infections Misses a Significant Proportion of Invasive Aspergillosis in Patients with Severe COVID-19. Journal of Fungi, 8(3), 273. https://doi.org/10.3390/jof8030273
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017). The Changing Epidemiology of Invasive Fungal Infections. Methods in Molecular Biology (Clifton, N.J.), 1508, 17–65. https://doi.org/10.1007/978-1-4939-6515-1_2
Erdem, I., Yıldırım, I., Safak, B., Karaali, R., Erdal, B., Ardic, E., Dogan, M., Kardan, M. E., Kavak, C., Sahin Karadil, K., Yildiz, E., Topcu, B., Kiraz, N., & Arar, C. (2022). A 5-year surveillance of healthcare-associated infections in a university hospital: A retrospective analysis. SAGE Open Medicine, 10, 20503121221091789. https://doi.org/10.1177/20503121221091789
Facciolà, A., Pellicanò, G. F., Visalli, G., Paolucci, I. A., Venanzi Rullo, E., Ceccarelli, M., D’Aleo, F., Di Pietro, A., Squeri, R., Nunnari, G., & La Fauci, V. (2019). The role of the hospital environment in the healthcare-associated infections: A general review of the literature. European Review for Medical and Pharmacological Sciences, 23(3), Artigo 3. https://doi.org/10.26355/eurrev_201902_17020
Inoue, Y., Kohno, S., Fujii, T., Otsubo, T., Mori, N., Ishino, T., Takase, T., Kaku, M., Koga, H., & Hara, K. (1995). Clinical evaluation of catheter-related fungemia and bacteremia. Internal Medicine (Tokyo, Japan), 34(6), 485–490. https://doi.org/10.2169/internalmedicine.34.485
Jupen, G. A., Montes, E. G., Bail, L., Rickli, G. Â. F., & Ito, C. A. S. (2023). Análise das infecções relacionadas à assistência à saúde e o consumo de antimicrobianos em uma Unidade de Terapia Intensiva neonatal. Peer Review, 5(23), 561–573. https://doi.org/10.53660/1349.prw2854
Karas, B., Souza, A. C. M. F. D., Jupen, G. A., Rickli, G. Â. F., Ito, C. A. S., Montes, E. G., Bail, L., & Gaspar, M. D. D. R. (2023). Analysis of Healthcare-Associated Infections in COVID-19 patients admitted to an Intensive Care Unit. Research, Society and Development, 12(5), e25412541772. https://doi.org/10.33448/rsd-v12i5.41772
Khandelwal, A., Chaudhary, S. C., Verma, A. K., Sawlani, K. K., Gupta, K. K., Himanshu, D., Sonkar, S. K., & Verma, S. K. (2023). Nontubercular Bacterial and Fungal Infections in Patients of Chronic Obstructive Pulmonary Disease. Annals of African Medicine, 22(1), 77–81. https://doi.org/10.4103/aam.aam_186_21
Khodavaisy, S., Sarrafnia, H., & Abdollahi, A. (2024). Outcomes of Patients with COVID-19 and Fungal Coinfections: A Systematic Review and Meta-Analysis Study. Iranian Journal of Pathology, 19(2), 137–147. https://doi.org/10.30699/ijp.2024.2010087.3160
Kołpa, M., Wałaszek, M., Gniadek, A., Wolak, Z., & Dobroś, W. (2018). Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland. International Journal of Environmental Research and Public Health, 15(1), 112. https://doi.org/10.3390/ijerph15010112
Komorowski, A. S., Aftanas, P., Porter, V., Katz, K., Kozak, R. A., & Li, X. X. (2024). Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Candida auris Screening Methods. Open Forum Infectious Diseases, 11(6), ofae017. https://doi.org/10.1093/ofid/ofae017
Kramer, A., Schwebke, I., & Kampf, G. (2006). How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infectious Diseases, 6(1), 130. https://doi.org/10.1186/1471-2334-6-130
Kumar, G., Adams, A., Hererra, M., Rojas, E. R., Singh, V., Sakhuja, A., Meersman, M., Dalton, D., Kethireddy, S., Nanchal, R., & Guddati, A. K. (2021). Predictors and outcomes of healthcare-associated infections in COVID-19 patients. International Journal of Infectious Diseases, 104, 287–292. https://doi.org/10.1016/j.ijid.2020.11.135
Lemiech-Mirowska, E., Kiersnowska, Z. M., Michałkiewicz, M., Depta, A., & Marczak, M. (2021). Nosocomial infections as one of the most important problems of healthcare system. Annals of Agricultural and Environmental Medicine: AAEM, 28(3), 361–366. https://doi.org/10.26444/aaem/122629
Li, Z., & Denning, D. W. (2023). The Impact of Corticosteroids on the Outcome of Fungal Disease: A Systematic Review and Meta-analysis. Current Fungal Infection Reports, 17(1), 54–70. https://doi.org/10.1007/s12281-023-00456-2
Lopes, J. P., & Lionakis, M. S. (2022). Pathogenesis and virulence of Candida albicans. Virulence, 13(1), Artigo 1. https://doi.org/10.1080/21505594.2021.2019950
Magalhães, Y. C., Bomfim, M. R. Q., Melônio, L. C., Ribeiro, P. C. S., Cosme, L. M., Rhoden, C. R., & Marques, S. G. (2015). Clinical significance of the isolation of Candida species from hospitalized patients. Brazilian Journal of Microbiology, 46(1), 117–123. https://doi.org/10.1590/S1517-838246120120296
McCarty, T. (2022). Candidemia and Severe Coronavirus Disease 2019: Which Risk Factors Are Modifiable? Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 74(5), Artigo 5. https://doi.org/10.1093/cid/ciab635
Mishra, P., Pandey, C., Singh, U., Gupta, A., Sahu, C., & Keshri, A. (2019). Descriptive statistics and normality tests for statistical data. Annals of Cardiac Anaesthesia, 22(1), 67. https://doi.org/10.4103/aca.ACA_157_18
Neto Junior, J. M., Dias, V. C., De Andrad Bastos, V. Q., De Andrade Bastos, L. Q., Bastos, A. N., Bastos, R. V., Silva, V. L., Ferreira Machado, A. B., & Diniz, C. G. (2024). Clinical and epidemiological aspects of Candida yeast infections and rational use of antifungals. Future Microbiology, 19(7), 577–584. https://doi.org/10.1080/17460913.2024.2342679
Öncü, B., Belet, N., Emecen, A. N., & Birinci, A. (2019). Health care-associated invasive Candida infections in children. Medical Mycology, 57(8), 929–936. https://doi.org/10.1093/mmy/myz005
Parasher, A. (2021). COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgraduate Medical Journal, 97(1147), 312–320. https://doi.org/10.1136/postgradmedj-2020-138577
Pasqualotto, A. C., Sukiennik, T. C. T., & Meis, J. F. (2019). Brazil is so far free from Candida auris. Are we missing something? The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases, 23(3), Artigo 3. https://doi.org/10.1016/j.bjid.2019.05.004
Poncelet, A., Ruelle, L., Konopnicki, D., Miendje Deyi, V. Y., & Dauby, N. (2021). Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration. Infectious Diseases Now, 51(3), 293–295. https://doi.org/10.1016/j.idnow.2020.12.003
Porto, A. P. M., Borges, I. C., Buss, L., Machado, A., Bassetti, B. R., Cocentino, B., Bicalho, C. S., Carrilho, C. M. D. M., Rodrigues, C., Neto, E. A. S., Girão, E. S., Piastrelli, F., Sapienza, G., Varkulja, G., Kolbe, K., Passos, L., Esteves, P., Gitirana, P., Feijó, R. D. F., … Costa, S. F. (2023). Healthcare-associated infections on the intensive care unit in 21 Brazilian hospitals during the early months of the coronavirus disease 2019 (COVID-19) pandemic: An ecological study. Infection Control & Hospital Epidemiology, 44(2), 284–290. https://doi.org/10.1017/ice.2022.65
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005). Candida Biofilms: An Update. Eukaryotic Cell, 4(4), Artigo 4. https://doi.org/10.1128/EC.4.4.633-638.2005
Röhrig, B., Prel, J.-B. D., Wachtlin, D., & Blettner, M. (2009). Types of Study in Medical Research. Deutsches Ärzteblatt International. https://doi.org/10.3238/arztebl.2009.0262
Sieben, R. G., Paternina-de La Ossa, R., Waack, A., Casale Aragon, D., Bellissimo-Rodrigues, F., Israel Do Prado, S., & Celia Cervi, M. (2024). Risk factors and mortality of candidemia in a children’s public hospital in Sao Paulo, Brazil. Revista Argentina de Microbiología, S0325754124000397. https://doi.org/10.1016/j.ram.2023.09.002
Silva, F. H. A. da, Paço, F. R., Reis, E., & Amaral, V. (2011). Saccharomyces cerevisiae infection: An unusual pathogen in the ICU. Revista Brasileira de Terapia Intensiva, 23, 108–111. https://doi.org/10.1590/S0103-507X2011000100017
Suehara, M. B., & Silva, M. C. P. D. (2023). Prevalência de fungos anemófilos no Brasil e a correlação com doenças respiratórias e infecções fúngicas. Ciência & Saúde Coletiva, 28(11), 3289–3300. https://doi.org/10.1590/1413-812320232811.08302022
Suleyman, G., & Alangaden, G. J. (2021). Nosocomial Fungal Infections. Infectious Disease Clinics of North America, 35(4), 1027–1053. https://doi.org/10.1016/j.idc.2021.08.002
Thomas-Rüddel, D. O., Schlattmann, P., Pletz, M., Kurzai, O., & Bloos, F. (2022). Risk Factors for Invasive Candida Infection in Critically Ill Patients. CHEST, 161(2), 345–355. https://doi.org/10.1016/j.chest.2021.08.081
Toassi, R. F. C., & Petry, P. C. (2020). Metodologia Científica aplicada à área da Saúde (2o ed). Editora da UFRGS. https://lume.ufrgs.br/bitstream/handle/10183/218553/001123326.pdf
Wisplinghoff, H., Ebbers, J., Geurtz, L., Stefanik, D., Major, Y., Edmond, M. B., Wenzel, R. P., & Seifert, H. (2014). Nosocomial bloodstream infections due to Candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities. International Journal of Antimicrobial Agents, 43(1), 78–81. https://doi.org/10.1016/j.ijantimicag.2013.09.005
Yamamoto, A. C. A., Rodrigues De Paula, C., Basili Dias, L., Tadano, T., Rodrigues Martins, É., Vasconcelos Ribeiro De Souza Amadio, J., & Hahn, R. C. (2012). Epidemiological and clinical characteristics of nosocomial candidiasis in university hospitals in Cuiabá – Mato Grosso, Brazil. Revista Iberoamericana de Micología, 29(3), 164–168. https://doi.org/10.1016/j.riam.2012.01.001
Yu, K. C., Jung, M., & Ai, C. (2023). Characteristics, costs, and outcomes associated with central-line–associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals. Infection Control & Hospital Epidemiology, 44(12), 1920–1926. https://doi.org/10.1017/ice.2023.132
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C., Denham, C. R., & Bates, D. W. (2013). Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Internal Medicine, 173(22), 2039–2046. https://doi.org/10.1001/jamainternmed.2013.9763
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pedro Henrique Cury Tonon; Amanda Bahls; Rubens Miguel Wesselovicz; Larissa Bail; Carmen Antônia Sanches Ito; Maria Dagmar da Rocha Gaspar; Elisangela Gueiber Montes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
